Fallopian Tube Cancer
📧 Sign up to get email alerts when something new happens for Fallopian Tube Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-05Clinical Trial Results: Durvalumab and Tremelimumab in Treating Participants With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
Phase 2 clinical trial assessing durvalumab and tremelimumab in recurrent or refractory ovarian, primary peritoneal, or fallopian tube cance…
-
CLINICAL_TRIALS trial_result · 2026-08-05Clinical Trial Results: Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod [Phase 2]
Phase 2 trial evaluating dendritic cell/tumor fusions with GM-CSF and Imiquimod in ovarian cancer and related peritoneal cancers; study term…
-
CLINICAL_TRIALS trial_result · 2026-06-22Clinical Trial Results: Trial Evaluating Feasibility and Quality of Life of Second Look Laparoscopy With Hyperthermic Intraperitoneal Chemotherapy [Phase 2]
Phase 2 trial assessing feasibility and quality of life of second-look laparoscopy with hyperthermic intraperitoneal chemotherapy in ovarian…
-
CLINICAL_TRIALS trial_result · 2026-06-18Clinical Trial Results: A Study of CRLX101(NLG207) in Combination With Weekly Paclitaxel in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer [Phase 1, Phase 2]
Phase 1/2 study evaluating CRLX101 (NLG207) with weekly paclitaxel in recurrent/persistent epithelial ovarian, Fallopian tube, or primary pe…
-
CLINICAL_TRIALS trial_result · 2026-06-12Clinical Trial Results: Olvi-Vec Oncolytic Immunotherapy in Patients With Recurrent or Refractory Ovarian Cancer [Phase 1, Phase 2]
Phase 1/2 trial results for Olvi-Vec oncolytic immunotherapy in recurrent or refractory ovarian cancer show completed study with posted resu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-06-02Clinical Trial Update: Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer [Phase 3]
A Phase 3 trial evaluating mirvetuximab soravtansine with bevacizumab versus bevacizumab alone as maintenance therapy in platinum-sensitive …
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Upfront Systematic Tumour BRCA Testing in Patients With High Grade Serous or Endometrioid Ovarian, Fallopian Tube or Primary Peritoneal Cancer (HGSEC): The t-BRCA Study
This clinical trial update reports the completed status of the t-BRCA study evaluating upfront BRCA testing in patients with high-grade sero…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers
This completed NCI clinical trial reports on predictors of relapse in fallopian tube cancer, peritoneal cancer, and epithelial ovarian cance…
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: Carboplatin, Gemcitabine Hydrochloride, and Berzosertib in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 1]
Phase 1 trial evaluating a carboplatin/gemcitabine hydrochloride/berzosertib combination in patients with recurrent or metastatic ovarian, f…
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib [Phase 2]
A Phase II trial evaluating nivolumab, bevacizumab, and rucaparib in peritoneal cancer, ovarian cancer, and fallopian tube cancer; results h…
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer [Phase 2]
Phase 2 trial evaluating oregovomab in combination with chemotherapy in the neoadjuvant setting for newly diagnosed advanced epithelial ovar…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial results evaluating metformin in combination with chemotherapy for patients with stage III–IV ovarian, fallopian tube,…
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Trial Evaluating Feasibility and Quality of Life of Second Look Laparoscopy With Hyperthermic Intraperitoneal Chemotherapy [Phase 2]
Phase 2 trial completed to assess feasibility and quality of life of a second-look laparoscopy with hyperthermic intraperitoneal chemotherap…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: A Study of Azenosertib (ZN-c3) and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer [Phase 1, Phase 2]
This clinical trial update reports the completion of a Phase 1/2 study evaluating the combination of Azenosertib (ZN-c3) and Niraparib in pl…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Analysis of the Clinical Experience With Rucaparib in the Rucaparib Access Program (RAP) in Spain - A GEICO Study
This update reports results from the Rucaparib Access Program (RAP) in Spain, summarizing clinical experience with rucaparib in patients wit…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Phenotypic Characterization Tumor-infiltrating Lymphocytes at Diagnosis and After Chemotherapy in Ovarian Cancer [NA]
The trial investigating phenotypic characterization of tumor-infiltrating lymphocytes in ovarian cancer and fallopian tube cancer at diagnos…
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer [Phase 1]
Phase 1 clinical trial evaluating MUC1-Activated T Cells for relapsed and resistant ovarian, fallopian tube, and primary peritoneal cancers;…
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Pamiparib Plus Surufatinib in Patients With Platinum-resistant Ovarian Cancer [Phase 1, Phase 2]
This is a clinical trial update on a Phase 1/2 study evaluating pamiparib plus surufatinib for platinum-resistant ovarian cancer and related…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Choices About Genetic Testing And Learning Your Risk With Smart Technology [NA]
A completed Rutgers-led trial evaluated choices about genetic testing and learning cancer risk using smart technology across multiple cancer…
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Genomic BRCA and Extensive ovArian Cancer Testing
A completed clinical trial evaluated BRCA genomic testing and extensive ovarian cancer testing in epithelial ovarian cancer, primary periton…
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Mirvetuximab Soravtansine Monotherapy in Platinum-Sensitive Epithelial, Peritoneal, and Fallopian Tube Cancers [Phase 2]
Phase 2 trial evaluating mirvetuximab soravtansine as monotherapy in platinum-sensitive epithelial ovarian cancer, peritoneal cancer, and fa…
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid Tumors [Phase 1]
Phase 1 study of Felmetatug Vedotin (SGN-B7H4V) in advanced solid tumors was terminated.
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: RC88 in Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer [Phase 2]
A Phase 2 trial of RC88 in platinum-resistant recurrent epithelial ovarian cancer, fallopian tube cancer, and primary peritoneal cancer has …
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Collection of Malignant Ascites, Pleural Fluid, and Blood From People With Solid Tumors
The National Cancer Institute-sponsored study collecting malignant ascites, pleural fluid, and blood from people with solid tumors has been …
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Phase 1b Study of SL-172154 Administered With Combination Agent(s) in Subjects With Ovarian Cancers [Phase 1]
Phase 1b study evaluating SL-172154 in combination with other agents in platinum-resistant ovarian, fallopian tube, and primary peritoneal c…